Covalon Technologies Financials

COV Stock  CAD 3.79  0.04  1.04%   
Please use analysis of Covalon Technologies fundamentals to determine if markets are correctly pricing the company. We were able to interpolate thirty-two available fundamental indicators for Covalon Technologies, which can be compared to its peers. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Covalon Technologies to be traded at C$3.68 in 90 days. Key indicators impacting Covalon Technologies' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio1.841.75
Sufficiently Up
Slightly volatile
Current Ratio4.644.72
Fairly Down
Slightly volatile
  
Understanding current and past Covalon Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Covalon Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Covalon Technologies' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Covalon Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Covalon Technologies. Check Covalon Technologies' Beneish M Score to see the likelihood of Covalon Technologies' management manipulating its earnings.

Covalon Technologies Stock Summary

Covalon Technologies competes with Biosyent, and Microbix Biosystems. Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. COVALON TECHNOLOGIES operates under Biotechnology classification in Exotistan and is traded on Commodity Exchange.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentCanada Stock View All
ExchangeTSX Venture Exchange
ISINCA22282D3022
Business Address1660 Tech Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.covalon.com
Phone905 568 8400
CurrencyCAD - Canadian Dollar
You should never invest in Covalon Technologies without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Covalon Stock, because this is throwing your money away. Analyzing the key information contained in Covalon Technologies' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Covalon Technologies Key Financial Ratios

There are many critical financial ratios that Covalon Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Covalon Technologies reports annually and quarterly.

Covalon Technologies Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets34.7M40.6M30.4M24.9M28.6M18.5M
Net Debt17.4M(20.4M)(11.9M)(7.2M)(6.5M)(6.2M)
Retained Earnings(47.7M)(24.2M)(33.9M)(38.4M)(34.5M)(36.3M)
Accounts Payable14.0M4.0M3.7M3.8M4.4M3.8M
Cash3.5M22.9M14.1M8.8M10.1M6.3M
Net Receivables3.3M6.4M4.7M6.2M7.1M7.4M
Inventory7.2M4.7M5.0M5.9M6.8M7.2M
Other Current Assets809.4K3.4M3.5M390.1K448.6K637.1K
Total Liab25.6M7.2M6.1M6.1M7.0M6.1M
Total Current Assets14.8M37.4M27.2M21.3M24.5M13.3M
Intangible Assets2.2M897.9K1.3M1.8M2.1M1.6M
Other Current Liab(10.1M)414.6K209.1K668.0K601.2K631.2K
Other Liab438.9K290.1K162.4K51.4K46.3K43.9K
Net Tangible Assets259.4K(5.6M)32.9M23.2M26.7M28.1M
Other Assets648.5K542.3K513.2K290.3K261.3K248.2K
Short Term Debt18.2M541.4K609.6K643.4K739.9K702.9K
Net Invested Capital26.8M33.4M24.2M18.8M21.6M25.1M
Net Working Capital(7.8M)32.4M22.7M16.1M18.5M13.4M

Covalon Technologies Key Income Statement Accounts

201920202021202220232024 (projected)
Operating Income(6.1M)838.3K(9.1M)(4.5M)(4.1M)(4.3M)
Ebit(5.6M)838.3K(9.1M)(4.5M)(4.1M)(4.3M)
Research Development794.2K1.1M1.1M1.4M1.6M982.7K
Ebitda(4.9M)1.5M(8.1M)(3.6M)(3.2M)(3.4M)
Income Before Tax(7.0M)419.0K(9.3M)(4.5M)(4.0M)(4.2M)
Net Income(7.0M)23.5M(9.7M)(4.5M)(5.1M)(4.9M)
Income Tax Expense999.8K(23.1M)409.3K801.5K721.3K757.4K
Interest Expense889.1K860.2K419.4K111.6K128.3K247.2K
Total Revenue25.8M19.6M18.1M26.6M30.6M32.1M
Gross Profit12.5M9.7M7.5M14.4M16.5M17.3M
Cost Of Revenue13.3M9.9M10.7M12.2M14.1M14.8M
Net Interest Income(860.2K)(419.4K)(111.6K)67.5K77.6K81.5K

Covalon Technologies Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory1.4M2.2M(63.4K)(1.0M)(939.2K)(892.3K)
Change In Cash(6.1M)19.4M(8.9M)(5.3M)(4.7M)(4.5M)
Free Cash Flow(4.4M)443.7K(9.1M)(4.5M)(4.1M)(3.8M)
Depreciation1.2M700.5K1.0M969.4K1.1M1.2M
Other Non Cash Items860.2K419.4K110.8K66.2K59.6K56.6K
Capital Expenditures371.1K177.7K1.1M1.3M1.5M1.6M
Net Income(7.0M)419.0K(9.3M)(4.5M)(4.0M)(4.2M)
End Period Cash Flow3.5M22.9M14.1M8.8M10.1M6.3M
Investments(370.4K)(278.5K)(843.0K)(1.5M)(1.3M)(1.4M)
Change To Netincome2.6M2.2M(22.8M)335.5K301.9K317.0K
Net Borrowings6.9M(1.1M)(8.0M)(585.2K)(526.7K)(500.3K)

Covalon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Covalon Technologies's current stock value. Our valuation model uses many indicators to compare Covalon Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Covalon Technologies competition to find correlations between indicators driving Covalon Technologies's intrinsic value. More Info.
Covalon Technologies is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At this time, Covalon Technologies' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Covalon Technologies' earnings, one of the primary drivers of an investment's value.

Covalon Technologies Systematic Risk

Covalon Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Covalon Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Covalon Technologies correlated with the market. If Beta is less than 0 Covalon Technologies generally moves in the opposite direction as compared to the market. If Covalon Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Covalon Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Covalon Technologies is generally in the same direction as the market. If Beta > 1 Covalon Technologies moves generally in the same direction as, but more than the movement of the benchmark.

Covalon Technologies Total Assets Over Time

Today, most investors in Covalon Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Covalon Technologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Covalon Technologies growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.19

At this time, Covalon Technologies' Price Earnings To Growth Ratio is fairly stable compared to the past year.

Covalon Technologies November 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Covalon Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Covalon Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Covalon Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Covalon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Covalon Technologies's daily price indicators and compare them against related drivers.

Additional Tools for Covalon Stock Analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.